Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JAS Diagnostics is a specialized manufacturer of clinical chemistry reagents and diagnostic systems for the global laboratory market. The company provides a comprehensive range of liquid-stable reagents, calibrators, and controls designed for use on various automated chemistry analyzers. Their product line supports critical diagnostic testing for metabolic, renal, and hepatic functions, as well as lipid management. Since its acquisition by Jant Pharmacal Corporation in 2011, JAS Diagnostics has continued to operate as a key provider of high-quality in vitro diagnostic (IVD) solutions. The company's focus on liquid-stable technology eliminates the need for reagent reconstitution, thereby improving laboratory efficiency and reducing the potential for errors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JAS Diagnostics.